Sort
15,273 grants matching “antimicrobial resistance”
Microbial exploration for new antimicrobial discovery
$1,898,854Akintunde Emiola · National Institute Of Dental & Craniofacial Research · ZIA · FY2024 · DE
Predicting the emergence of antibiotic resistance through multi-omics approaches and Immune System-surveillan
$1,895,142Tim Van Opijnen · Boston College · U01 · FY2019 · AI
Comprehensive Sickle Cell Center
$1,893,234St. Jude Children'S Research Hospital · U54 · FY2004 · HL
PREBIOTIC INULIN TO LIMIT ANTIMICROBIAL-RESISTANT INFECTIONS DURING CRITICAL ILLNESS: A PHASE II CLINICAL TRIAL
$1,890,421The Trustees Of Columbia University In The City Of New York · · FY2019 · Defense Health Agency
NOVEL ANTIMICROBIAL HYBRID HYDROGEL DRESSING TARGETING WOUND INFECTIONS CAUSED BY SUPERBUGS RESISTANT TO ALL CURRENT ANTIBIOTICS
$1,888,916University Of North Carolina At Chapel Hill · · FY2020 · Defense Health Agency
STRENGTHENING THE ANTIMICROBIAL ARSENAL OF THE INTESTINAL EPITHELIUM TO COUNTERACT MULTIDRUG-RESISTANT ENTERIC PATHOGENS
$1,878,300The Cleveland Clinic Foundation · · FY2019 · Department of the Army
Predicting the emergence of antibiotic resistance through multi-omics approaches and Immune System-surveillan
$1,876,314Tim Van Opijnen · Boston College · U01 · FY2020 · AI
Application of Genomic Approaches to Bacterial Pathogenesis and Mechanisms of Antimicrobial Resistance
$1,867,486John Dekker · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Vaccine and Treatment Evaluation Units
$1,866,737Nadine Georges Rouphael · Emory University · UM1 · FY2021 · AI
Starve and Kill: Engineered Antigens Targeting Nutrient Acquisition Pathways Essential for Gonococcal Infection and Disease
$1,866,512Cynthia Nau Cornelissen · Georgia State University · U19 · FY2021 · AI
Systems Biology Approach to Redefine Susceptibility Testing and Treatment of MDR Pathogens in the Context of Host Immunity
$1,859,004Bernhard O Palsson · University Of California, San Diego · U01 · FY2019 · AI
COBRE Center for Antimicrobial Resistance and Therapeutic Discovery
$1,858,738Eleftherios Mylonakis · Miriam Hospital · P20 · FY2021 · GM
Resolving the bottleneck in antibiotic discovery
$1,857,306Kim Lewis · Northeastern University · P01 · FY2016 · AI
Biomolecular Structure and Mechanism, Structure-Based Drug Design
$1,856,135Xinhua Ji · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Proof of Principle Evaluation of IV Gallium Nitrate in Patients with CF
$1,853,439Christopher Hooper Goss · University Of Washington · UM1 · FY2015 · HL
CLINICAL TRIAL FOR COMMUNITY-ACQUIRED METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS
$1,845,000Andrew Boulter · University Of California, San Francisco · N01 · FY2014 · AI
Mechanisms of non-classical multidrug resistance in cancer
$1,844,598Michael Gottesman · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Clinical trial of trimethoprim-sulfamethoxazole or chloroquine in adults on ART
$1,841,146Miriam K Laufer · University Of Maryland Baltimore · U01 · FY2012 · AI
Comprehensive Sickle Cell Center
$1,839,707St. Jude Children'S Research Hospital · U54 · FY2003 · HL
Novel Therapeutics for Bacillus anthracis
$1,835,180University Of Illinois At Chicago · U19 · FY2003 · AI
COBRE Center for Antimicrobial Resistance and Therapeutic Discovery
$1,832,044Erika M D'agata · Miriam Hospital · P20 · FY2022 · GM
TASK A28: ADVANCED SMALL ANIMAL MODELS FOR THE TESTING OF CANDIDATE PREVENTIVE INTERVENTION AGAINST MYCOBACTERIUM TUBERCULOSIS
$1,830,908Angelo Izzo · Colorado State University · N01 · FY2019 · AI
Starve and Kill: Engineered Antigens Targeting Nutrient Acquisition Pathways Essential for Gonococcal Infection and Disease
$1,819,769Cynthia Nau Cornelissen · Georgia State University · U19 · FY2020 · AI
Developing Novel Antibiotics Against Yersinia pestis
$1,811,326Losee Lucy Ling · Novobiotic Pharmaceuticals, Llc · R44 · FY2007 · AI
Starve and Kill: Engineered Antigens Targeting Nutrient Acquisition Pathways Essential for Gonococcal Infection and Disease
$1,808,328Cynthia Nau Cornelissen · Georgia State University · U19 · FY2023 · AI